Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Plasma Cell Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Early research (Phase 1)Active Not RecruitingNCT05823571
What this trial is testing

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

Who this might be right for
Leukemia, AcuteMyelodysplastic SyndromesMyelomonocytic Leukemia, Chronic+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)Study completedNCT02780609
What this trial is testing

Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 22
Not applicableUnknownNCT01572688
What this trial is testing

Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shandong Lanjin Pharmaceuticals Co.,Ltd 60
Testing effectiveness (Phase 2)Looking for participantsNCT06100237
What this trial is testing

Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

Who this might be right for
Multiple Myeloma
Carl Ola Landgren, MD, PhD 50
Early research (Phase 1)Study completedNCT01342289
What this trial is testing

Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

Who this might be right for
Hodgkin's LymphomaLeukemiaMyelodysplastic Syndrome(MDS)+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 127
Testing effectiveness (Phase 2)Looking for participantsNCT06140966
What this trial is testing

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaPrimary Plasma Cell LeukemiaExtramedullary Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 54
Testing effectiveness (Phase 2)WithdrawnNCT01660997
What this trial is testing

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00113932
What this trial is testing

UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 140
Not applicableUnknownNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Testing effectiveness (Phase 2)Study completedNCT01775553
What this trial is testing

Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Ajai Chari 13
Testing effectiveness (Phase 2)Study completedNCT00003402
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
University of Maryland, Baltimore 35
Testing effectiveness (Phase 2)UnknownNCT01665014
What this trial is testing

Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice 50
Post-approval studies (Phase 4)Study completedNCT00352703
What this trial is testing

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

Who this might be right for
Non-Hodgkin's LymphomaMultiple Myeloma
Swedish Orphan Biovitrum 145
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05014646
What this trial is testing

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT01729091
What this trial is testing

Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell LeukemiaPlasma Cell Myeloma
M.D. Anderson Cancer Center 72
Not applicableStudy completedNCT02997813
What this trial is testing

Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies

Who this might be right for
Multiple MyelomaBlood Stem Cell Transplant Failure
Intergroupe Francophone du Myelome 112
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07648459
What this trial is testing

CM336-SOC for Dynamically High-Risk Multiple Myeloma Study

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 46
Large-scale testing (Phase 3)Study completedNCT01208818
What this trial is testing

Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy

Who this might be right for
Chronic Renal Failure With Uremic Nephropathy
Assistance Publique - Hôpitaux de Paris 284
Next Page